BioArctic AB (OSTO:BIOA B)
kr 238.4 5 (2.14%) Market Cap: 21.06 Bil Enterprise Value: 20.57 Bil PE Ratio: 0 PB Ratio: 21.21 GF Score: 55/100

Q2 2019 BioArctic AB Earnings Call Transcript

Jul 11, 2019 / 07:30AM GMT
Release Date Price: kr71.7 (-0.42%)
Operator

Hello and welcome to the BioArctic Q2 2019 report.(Operator Instructions) Just to remind you, this conference call is being recorded. Today, I am pleased to present CEO, Gunilla Osswald and CFO, Jan Mattsson. Please go ahead with your meeting.

Gunilla Osswald;publ;CEO
BioArctic AB

()-

Thank you so much. And most welcome to the BioArctic interim report for the first half of 2019. I'm Gunilla Osswald, and I'm the CEO of BioArctic. And I will share the presentation here today with our CFO, Jan Mattsson.

Next slide, please. BioArctic is listed on Nasdaq Stockholm mid-cap stock market, and this is our disclaimer.

Next slide, please. So today, I will start with a summary of our significant projects -- progress that we have had in all our areas during the first half of this year. Last year was a fantastic year for BioArctic, and this first half of this year has continued to show great progress in all 3 disease areas as well as in our technology platform area.

If we start with Alzheimer's disease. Our most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot